Vaxil Bio (TSXV:VXL) Total Stockholders Equity : C$0.89 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Total Stockholders Equity?

Vaxil Bio's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$0.89 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vaxil Bio's Book Value per Share for the quarter that ended in Dec. 2023 was C$0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vaxil Bio's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Vaxil Bio Total Stockholders Equity Historical Data

The historical data trend for Vaxil Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Total Stockholders Equity Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-0.58

0.80

1.70

1.14

0.89

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															1.14	1.01	0.89	0.86	0.89

Vaxil Bio (TSXV:VXL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vaxil Bio's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.891	-	0)	/	136.979
	=	0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vaxil Bio's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.891
	=	0.00

Vaxil Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines